China NT Pharma Group Company Limited

SEHK:2965 Voorraadrapport

Marktkapitalisatie: HK$68.7m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

China NT Pharma Group Beheer

Beheer criteriumcontroles 3/4

China NT Pharma Group's CEO is David Ng, appointed in Jan 1995, has a tenure of 29.58 years. total yearly compensation is CN¥1.67M, comprised of 99% salary and 1% bonuses, including company stock and options. directly owns 0.009% of the company’s shares, worth HK$6.50K. The average tenure of the management team and the board of directors is 2.7 years and 7.2 years respectively.

Belangrijke informatie

David Ng

Algemeen directeur

CN¥1.7m

Totale compensatie

Percentage CEO-salaris99.0%
Dienstverband CEO29.6yrs
Eigendom CEO0.009%
Management gemiddelde ambtstermijn2.7yrs
Gemiddelde ambtstermijn bestuur7.2yrs

Recente managementupdates

Geen updates

Recent updates

Geen updates

Analyse CEO-vergoeding

Hoe is David Ng's beloning veranderd ten opzichte van China NT Pharma Group's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Dec 31 2023CN¥2mCN¥2m

-CN¥33m

Jun 30 2023n/an/a

-CN¥44m

Mar 31 2023n/an/a

-CN¥55m

Dec 31 2022CN¥2mCN¥2m

-CN¥50m

Sep 30 2022n/an/a

-CN¥121m

Jun 30 2022n/an/a

-CN¥175m

Mar 31 2022n/an/a

-CN¥162m

Dec 31 2021CN¥2mCN¥1m

-CN¥150m

Sep 30 2021n/an/a

-CN¥147m

Jun 30 2021n/an/a

-CN¥145m

Mar 31 2021n/an/a

-CN¥167m

Dec 31 2020CN¥2mCN¥2m

-CN¥189m

Sep 30 2020n/an/a

-CN¥271m

Jun 30 2020n/an/a

-CN¥353m

Mar 31 2020n/an/a

-CN¥351m

Dec 31 2019CN¥6mCN¥6m

-CN¥350m

Sep 30 2019n/an/a

-CN¥547m

Jun 30 2019n/an/a

-CN¥744m

Mar 31 2019n/an/a

-CN¥670m

Dec 31 2018CN¥9mCN¥6m

-CN¥596m

Sep 30 2018n/an/a

-CN¥190m

Jun 30 2018n/an/a

CN¥216m

Mar 31 2018n/an/a

CN¥215m

Dec 31 2017CN¥8mCN¥6m

CN¥214m

Compensatie versus markt: David's total compensation ($USD232.93K) is about average for companies of similar size in the Hong Kong market ($USD235.36K).

Compensatie versus inkomsten: David's compensation has increased whilst the company is unprofitable.

CEO

David Ng (60 yo)

29.6yrs

Tenure

CN¥1,669,000

Compensatie

Mr. Tit Ng, also known as David, has been the Chief Executive Officer and Chairman of China NT Pharma Group Company Limited since 1995. He is a Co-Founder of NT Pharma Group Company Limited. Mr. Ng was app...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Tit Ng
Co-Founder29.6yrsCN¥1.67m0.0095%
CN¥ 6.5k
Jing Fang
Chief Financial Officer4.8yrsgeen gegevensgeen gegevens
Ching Mei Ng
Executive Directorless than a yeargeen gegevensgeen gegevens
Cheung Cheng
Company Secretaryless than a yeargeen gegevensgeen gegevens

2.7yrs

Gemiddelde duur

44yo

Gemiddelde leeftijd

Ervaren management: 2965's management team is considered experienced (2.7 years average tenure).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Tit Ng
Co-Founder29.6yrsCN¥1.67m0.0095%
CN¥ 6.5k
Ching Mei Ng
Executive Directorless than a yeargeen gegevensgeen gegevens
Yu Chin
Non-Executive Director14.4yrsCN¥138.00k0.0095%
CN¥ 6.5k
Wei Qian
Non-Executive Director14.4yrsgeen gegevensgeen gegevens
Tze Shan Yu
Independent Non-Executive Director7.2yrsCN¥138.00k0.0057%
CN¥ 3.9k
Ming Kwan Ng
Independent Non-Executive Director1.6yrsCN¥138.00kgeen gegevens
Yubiao Zhao
Independent Non-Executive Director4.7yrsCN¥138.00kgeen gegevens

7.2yrs

Gemiddelde duur

60yo

Gemiddelde leeftijd

Ervaren bestuur: 2965's board of directors are considered experienced (7.2 years average tenure).